Chairperson - Dilip D Dandekar
MD - Ashish S Dandekar
Directors - Abeezar E Faizullabhoy, Ashish S Dandekar, Bhargav A Patel, Bhargav Patel, D R Puranik, Dattatraya R Puranik, Dilip D Dandekar, N R Joshi, Narayan R Joshi, Pramod M Sapre, Sharad M Kulkarni

Total Income - Rs. 1263.394 Million ( year ending Mar2010)
Net Profit - Rs. 42.868 Million ( year ending Mar2010)

Camlin, the corporate group, was established in 1931 and is a pioneer in art and stationery material in India. Camlin diversified into Pharmaceuticals and Fine Chemicals two decades ago. The Fine Chemical Division of Camlin got de-merged into a separate company named as Camlin Fine Chemicals on 22nd December 2006. The entire management team and employees of Camlin Fine Chemicals Division are now a part of the independent legal entity formed under the Indian Companies Act 1956.

Camlin Fine Chemicals is the world's second largest manufacturer and marketer of food grade antioxidants TBHQ and BHA. Its mission is to be the largest food antioxidant and ingredient manufacturer worldwide. Their facilities are HACCP and ISO 9001 : 2000 certified.

Subsidiary Details:

• Chemolutions Chemicals: Specialty Chemical Intermediates
• Sangam Laboratories: Nutraceuticals
• Fine Renewable Energy.
• Fine LifeStyle Brands: Luxury Fashion Brands

Recent Developments:

On 6^th June 2008 - The company entered into a joint venture, on 51:49 basis, with US based Viachem LLC, to set up a joint venture company under the name Dulcette Technologies for marketing Sucralose, Aspartame, and Acesulfame-K, and their belnds in USA, Canada, and Maxico.

On 7^th July 2008 - The Board of Directors of the company at its meeting held on 29th July 2008, approved the proposal for setting up a joint venture company with Pagoda Advisors and their associates.

As per the deal, Camlin Fine Chemicals will get 51% of the equity of the proposed new company and the rest 49% will be owned by Pagoda Advisors and their associates.The proposed new company will focus on the retail of luxury/premium brands in India by setting up stores in all stores in all major metros and cities in India by itself and through franchisees.

On 25^th February 2008: Camlin Fine Chemicals acquired 60% equity stake in Sangam Laboratories, a Small Scale Unit manufacturing Nutraceuticals and Drug Intermediates at Tarapur.

On 12^th February 2008 The company inked a joint venture deal with US based Advanced Aerospace Technologies to manufacture and market speciality fine chemicals primarily to cater to European and U.S markets.